InnovAge Holding Corp. Selling and Marketing Expense
InnovAge Holding Corp. (INNV) reported Selling and Marketing Expense of $34.36 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-09-09
- InnovAge Holding Corp. selling and marketing expense for the quarter ending 2026-06-30 was $9.93M, a 39.90% increase year-over-year.
- InnovAge Holding Corp. selling and marketing expense for the quarter ending 2026-03-31 was $8.74M, a 26.32% increase year-over-year.
- InnovAge Holding Corp. selling and marketing expense for the quarter ending 2025-12-31 was $8.08M, a 4.85% increase year-over-year.
- InnovAge Holding Corp. selling and marketing expense for the quarter ending 2025-09-30 was $7.61M, a 17.14% increase year-over-year.
- InnovAge Holding Corp. selling and marketing expense for fiscal 2026 was $34.36M, a 21.77% increase from fiscal 2025.
- InnovAge Holding Corp. selling and marketing expense for fiscal 2025 was $28.22M, a 13.06% increase from fiscal 2024.
- InnovAge Holding Corp. selling and marketing expense for fiscal 2024 was $24.96M, a 27.16% increase from fiscal 2023.
- InnovAge Holding Corp. selling and marketing expense for fiscal 2023 was $19.63M, a 18.90% decline from fiscal 2022.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $18.68M derived: sum of 2 quarters · filed 2026-09-09 | $26.75M derived: sum of 3 quarters · filed 2026-09-09 | $34.36M 10-K · filed 2026-09-09 |
| 2026-03-31 | $8.74M 10-Q · filed 2026-05-08 | $16.82M derived: sum of 2 quarters · filed 2026-05-08 | $24.43M 10-Q · filed 2026-05-08 | $31.53M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $8.08M 10-Q · filed 2026-02-03 | $15.68M 10-Q · filed 2026-02-03 | $22.78M derived: sum of 3 quarters · filed 2026-09-09 | $29.70M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $7.61M 10-Q · filed 2025-11-04 | $14.71M derived: sum of 2 quarters · filed 2026-09-09 | $21.63M derived: sum of 3 quarters · filed 2026-09-09 | $29.33M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $14.02M derived: sum of 2 quarters · filed 2026-09-09 | $21.73M derived: sum of 3 quarters · filed 2026-09-09 | $28.22M 10-K · filed 2026-09-09 |
| 2025-03-31 | $6.92M 10-Q · filed 2026-05-08 | $14.63M derived: sum of 2 quarters · filed 2026-05-08 | $21.12M 10-Q · filed 2026-05-08 | $27.66M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $7.70M 10-Q · filed 2026-02-03 | $14.20M 10-Q · filed 2026-02-03 | $20.74M derived: sum of 3 quarters · filed 2026-02-03 | $27.92M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $6.49M 10-Q · filed 2025-11-04 | $13.03M derived: sum of 2 quarters · filed 2025-11-04 | $20.21M derived: sum of 3 quarters · filed 2025-11-04 | $26.07M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $13.72M derived: sum of 2 quarters · filed 2025-09-09 | $19.58M derived: sum of 3 quarters · filed 2025-09-09 | $24.96M 10-K · filed 2025-09-09 |
| 2024-03-31 | $7.18M 10-Q · filed 2025-05-06 | $13.04M derived: sum of 2 quarters · filed 2025-05-06 | $18.42M 10-Q · filed 2025-05-06 | $24.54M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $5.86M 10-Q · filed 2025-02-04 | $11.24M 10-Q · filed 2025-02-04 | $17.36M derived: sum of 3 quarters · filed 2025-02-04 | $22.68M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $5.38M 10-Q · filed 2024-11-05 | $11.50M derived: sum of 2 quarters · filed 2024-11-05 | $16.82M derived: sum of 3 quarters · filed 2024-11-05 | $20.59M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $11.44M derived: sum of 2 quarters · filed 2024-09-10 | $15.21M derived: sum of 3 quarters · filed 2024-09-10 | $19.63M 10-K · filed 2024-09-10 |
| 2023-03-31 | $5.31M 10-Q · filed 2024-05-07 | $9.09M derived: sum of 2 quarters · filed 2024-05-07 | $13.50M 10-Q · filed 2024-05-07 | $18.59M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $3.77M 10-Q · filed 2024-02-06 | $8.19M 10-Q · filed 2024-02-06 | $13.27M derived: sum of 3 quarters · filed 2024-02-06 | $19.41M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $4.41M 10-Q · filed 2023-11-07 | $9.50M derived: sum of 2 quarters · filed 2023-11-07 | $15.64M derived: sum of 3 quarters · filed 2023-11-07 | $22.32M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $11.23M derived: sum of 2 quarters · filed 2023-09-12 | $17.91M derived: sum of 3 quarters · filed 2023-09-12 | $24.20M 10-K · filed 2023-09-12 |
| 2022-03-31 | $6.14M 10-Q · filed 2023-05-09 | $12.82M derived: sum of 2 quarters · filed 2023-05-09 | $19.12M 10-Q · filed 2023-05-09 | $27.02M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $6.68M 10-Q · filed 2023-02-07 | $12.97M 10-Q · filed 2023-02-07 | $20.87M derived: sum of 3 quarters · filed 2023-02-07 | $26.46M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $6.29M 10-Q · filed 2022-11-08 | $14.19M derived: sum of 2 quarters · filed 2022-11-08 | $19.79M derived: sum of 3 quarters · filed 2022-11-08 | $24.42M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $13.49M derived: sum of 2 quarters · filed 2022-09-13 | $18.12M derived: sum of 3 quarters · filed 2022-09-13 | $22.24M 10-K · filed 2022-09-13 |
| 2021-03-31 | $5.59M 10-Q · filed 2022-05-10 | $10.22M derived: sum of 2 quarters · filed 2022-05-10 | $14.34M 10-Q · filed 2022-05-10 | $18.93M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $4.63M 10-Q · filed 2022-02-09 | $8.74M 10-Q · filed 2022-02-09 | $13.34M derived: sum of 3 quarters · filed 2022-02-09 | $17.97M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | $4.11M 10-Q · filed 2021-11-09 | $8.71M derived: sum of 2 quarters · filed 2021-11-09 | $13.34M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $9.22M derived: sum of 2 quarters · filed 2021-09-23 | $19.00M 10-K · filed 2021-09-23 | |
| 2020-03-31 | $4.63M 10-Q · filed 2021-05-11 | $14.40M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |